Перспективы цитопротективной терапии у больных с хроническим легочным сердцем
Published in Russian Cardiology Journal (Russian Cardiology Society) • Oct 28, 2010
Authors:,,
С. А. Суроткина
А. А. Котляров
Н. М. Селезнева
Abstract
The study investigated effectiveness and safety of a cytoprotector mexicor in patients with chronic cor pulmonale (CCP). All participants (n=56; age 38-80 years) were divided into four groups. Group I (n=16) received a standard pulmonary therapy, while Group II (n=20) also received mexicor (300 mg/d...
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!